New research has found that a drug used to treat severe forms of acne reduces the availability of the chemical serotonin, low levels of which have been linked to aggression and clinical depression.
In a study published on Monday in the journal Experimental Biology and Medicine, scientists reveal a potential mechanism that might link the drug Roaccutane to reported cases of depression in some patients taking the medication.
The researchers had previously reported that the drug caused depressive behavior in mice but until now the mechanism by which this might happen was unknown.
Using cells cultured in a laboratory, scientists from the University of Bath in Britain and University of Texas were able to monitor the effect of the drug on the chemistry of the cells that produce serotonin.
They found that the cells significantly increased production of proteins and cell metabolites that are known to reduce the availability of serotonin.
This, says scientists, could disrupt the process by which serotonin relays signals between neurons in the brain and may be the cause of depression-related behavior.
In the brain, serotonin is thought to play an important role in the regulation of a range of behaviors, such as aggression, anger and sleep.
Low levels of serotonin have been linked to depression, as well as bipolar and anxiety disorders. Many medications aimed at treating depression seek to increase levels of serotonin to help overcome these problems.
"Our findings suggest that Roaccutane might disrupt the way serotonin is produced and made available to the cells," said Sarah Bailey at the University of Bath. "We are currently looking into this mechanism in more detail."
Source: Xinhua
|
Comment
Tell A Friend
Print Format
Save Article